Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements & Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements & Reports
Announcements & Reports
>
ASX Announcements
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
18 Jan 2024
FDA Clearance Amplia's IND for Pancreatic Cancer Trial in US
17 Jan 2024
Amplia Reports First Patient Dosing In Phase 2a Accent Trial
02 Jan 2024
Change of Director's Interest Notice - Dr Warwick Tong
02 Jan 2024
Change of Director's Interest Notice - Dr Chris Burns
02 Jan 2024
Change of Director's Interest Notice - Dr Robert Peach
02 Jan 2024
Change of Director's Interest Notice - Jane Bell
02 Jan 2024
Notification of cessation of securities - ATX
02 Jan 2024
Application for quotation of securities - ATX
Previous
1
2